--- title: "WATERS CORP /DE/ (WAT) stock: news and investor profile" url: "https://aibio.space/companies/waters-de/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "WATERS CORP /DE/ (NYSE: WAT), United States. Listing facts, related biotech companies and news on aibio.space." --- WAT WATERS CORP /DE/ NYSE · United States # WATERS CORP /DE/ (WAT) news WATERS CORP /DE/ is a public biotech or pharmaceutical company listed on NYSE under the ticker WAT, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest WATERS CORP /DE/ news We have not published a story on WATERS CORP /DE/ yet. When there is news, it will appear here. ## WATERS CORP /DE/ at a glance - **Ticker**: WAT - **Listing**: NYSE - **Country**: United States - **Cash, Jul 4, 2026**: $539.0 million ### Related companies - [GELSTAT CORP](https://aibio.space/companies/gelstat/) OTC: GSAC - [CHARLES RIVER LABORATORIES INTERNATIONAL, INC.](https://aibio.space/companies/charles-river-laboratories-international/) NYSE: CRL - [IQVIA HOLDINGS INC.](https://aibio.space/companies/iqvia/) NYSE: IQV - [Guardant Health](https://aibio.space/companies/guardant-health/) NASDAQ: GH - [InfuSystem Holdings](https://aibio.space/companies/infusystem/) NYSE: INFU - [Charlie's Holdings](https://aibio.space/companies/charlie-s/) OTC: CHUC - [Lucid Diagnostics](https://aibio.space/companies/lucid-diagnostics/) NASDAQ: LUCD - [METTLER TOLEDO INTERNATIONAL INC/](https://aibio.space/companies/mettler-toledo-international/) NYSE: MTD ### Also on NYSE - [LABCORP HOLDINGS INC.](https://aibio.space/companies/labcorp/) LH - [Alto Neuroscience](https://aibio.space/companies/alto-neuroscience/) ANRO - [Abbott Laboratories](https://aibio.space/companies/abbott-laboratories/) ABT - [Nuvation Bio](https://aibio.space/companies/nuvation-bio/) NUVB - [KONINKLIJKE PHILIPS NV](https://aibio.space/companies/koninklijke-philips/) PHG - [IQVIA HOLDINGS INC.](https://aibio.space/companies/iqvia/) IQV ## WATERS CORP /DE/ annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$3.17 billion](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | [$2.96 billion](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | | Research and development | [$195.7 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | [$183.0 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | | Net income (loss) | [$642.6 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | [$637.8 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | | Cash from operations | [$652.6 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | [$762.1 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | | Cash and equivalents | [$588.0 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526344691/) | [$325.4 million](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/) | | Short-term investments | | [$934,000](https://www.sec.gov/Archives/edgar/data/1000697/000119312525034579/) | Latest balance sheet, Jul 4, 2026 (10-Q): cash and equivalents $539.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about WATERS CORP /DE/ What is the ticker symbol of WATERS CORP /DE/? WATERS CORP /DE/ trades under the ticker WAT on NYSE. Where is WATERS CORP /DE/ listed? WATERS CORP /DE/ is listed on NYSE. Which country or territory is WATERS CORP /DE/ listed under? Our directory records WATERS CORP /DE/ under United States. Does aibio.space cover WATERS CORP /DE/? aibio.space lists WATERS CORP /DE/ among 2,820 public biotech companies and publishes its news here as stories appear. What was WATERS CORP /DE/'s revenue last year? $3.17 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is WATERS CORP /DE/ profitable? WATERS CORP /DE/ reported net income of $642.6 million for the fiscal year ended Dec 31, 2025, and generated $652.6 million of cash from operations, per its annual report to the SEC. How much does WATERS CORP /DE/ spend on research and development? $195.7 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does WATERS CORP /DE/ have? $539.0 million in cash at Jul 4, 2026, per its 10-Q. ## Investor discussion: WATERS CORP /DE/ Members talk about WATERS CORP /DE/ (WAT). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:WAT on TradingView](https://www.tradingview.com/symbols/NYSE-WAT/). ## Listing details WATERS CORP /DE/ is a public biotech or pharmaceutical company listed on NYSE under the ticker WAT, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: WATERS CORP /DE/ - **Ticker**: WAT - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/waters-de/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "WATERS CORP /DE/ (WAT) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/waters-de/